PubMed HealthSearch

PubMed · 4613516

Anesthesia mortality.

Abstract

Since the first report in 1846 on the use of anesthesia for a surgical procedure, deaths have occurred with practically every agent and technique used. Those mishaps of which we are aware are probably just a small segment of those that have actually occurred, since presently there is no widely used method for identifying anesthesia-associated deaths. Several sources of information are available, including the United States National Center for Health Statistics and articles in the medical literature. Neither of these encompasses more than a fraction of the total experience; in addition, the population upon which most reports are based and the number of anesthesias involved are usually not available as a denominator in determining the incidence of mishaps and the magnitude of the problem. Extrapolating from data from community anesthesia study committees and from population and operative figures, we can estimate that there are over 5,000 deaths associated with anesthesia in this country each year. This is 3 times as many as are caused by muscular dystrophy and multiple sclerosis, 15 times as many as with sickle cell anemia, 20 times as many as with myasthenia gravis and 40 times as many with poliomyelitis. We thus must recognize that anesthesia is an iatrogenic disease that deserves serious attention as a public health problem.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

O C Phillips, L S Capizzi. 1974. Anesthesia mortality.. https://pubmed.ncbi.nlm.nih.gov/4613516/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Yohimbine/flumazenil antagonism of hemodynamic alterations induced by a combination of midazolam, xylazine, and butorphanol in dogs.

Reversal of hemodynamic alterations induced by midazolam maleate (1.0 mg/kg of body weight), xylazine hydrochloride (0.44 mg/kg), and butorphanol tartrate (0.1 mg/kg) with yohimbine (0.1 mg/kg) and flumazenil (0.25 mg/kg) was evaluated in 5 dogs. The dogs were anesthetized with isoflurane for instrumentation. With return to consciousness, baseline values were recorded, and the midazolam/xylazine/butorphanol mixture with glycopyrrolate was administered IV. Hemodynamic data were recorded for 60 minutes, and then a reversal mixture of yohimbine and flumazenil was administered IV. All variables were measured 1 minute from beginning of the reversal injection. Mean arterial pressure, pulmonary arterial pressure, systemic vascular resistance, and right ventricular stroke work index increased significantly (P < 0.05) above baseline at 60 minutes. Cardiac index and central venous pressure significantly decreased below baseline at 60 minutes. After reversal, mean arterial pressure and central venous pressure significantly decreased from baseline, whereas cardiac index, pulmonary arterial pressure, and right ventricular stroke work index increased significantly above baseline. Heart rate, cardiac index, and right ventricular stroke work index increased significantly above the 60-minute value after reversal. Mean arterial pressure and systemic vascular resistance decreased significantly (P < 0.05) below the 60-minute value after reversal. The hemodynamic alterations accompanying midazolam/xylazine/butorphanol sedation-anesthesia may be rapidly reversed with a combination of yohimbine and flumazenil.

Anesthesia

[Controversial aspects of stage I skin melanomas].

Melanoma is still the most frequent cause of death for diseases arising in the skin. The mortality rate is approximately 25%, tumor thickness, sex and localization being the most important prognostic factors. It is still unclear whether the margin of excision, type of anaesthesia and the pattern of follow-up should be taken into consideration in relation to the individual prognostic groups.

Anesthesia